Paroxysmal supraventricular tachycardia and Sebaceous glands overactivity
Summary:
Sebaceous glands overactivity is reported only by a few people with Paroxysmal supraventricular tachycardia.
The study analyzes which people have Sebaceous glands overactivity with Paroxysmal supraventricular tachycardia. It is created by eHealthMe based on 2 people who have Sebaceous glands overactivity and Paroxysmal supraventricular tachycardia from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who have Paroxysmal Supraventricular Tachycardia and Sebaceous Glands Overactivity are studied.
What is Paroxysmal supraventricular tachycardia?
Paroxysmal supraventricular tachycardia is found to be associated with 2,424 drugs and 1,733 conditions by eHealthMe.
What is Sebaceous glands overactivity?
Sebaceous glands overactivity (excess secretion by sebaceous gland) is found to be associated with 60 drugs and 54 conditions by eHealthMe.
Number of Sebaceous glands overactivity in Paroxysmal supraventricular tachycardia reports submitted per year:

Gender of people who have Paroxysmal Supraventricular Tachycardia and experienced Sebaceous Glands Overactivity *:
- female: 100 %
- male: 0.0 %
Age of people who have Paroxysmal Supraventricular Tachycardia and experienced Sebaceous Glands Overactivity *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common co-existing conditions for these people *:
- Parkinson's Disease: 2 people, 100.00%
- High Blood Cholesterol: 2 people, 100.00%
Common drugs taken by these people *:
- Tenormin: 2 people, 100.00%
- Lipitor: 2 people, 100.00%
- Azilect: 2 people, 100.00%
- Cozaar: 1 person, 50.00%
Common symptoms for these people *:
- Impaired Healing: 2 people, 100.00%
- High Blood Pressure: 2 people, 100.00%
- Dry Skin: 2 people, 100.00%
- Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 2 people, 100.00%
- Taste - Impaired: 1 person, 50.00%
- Rashes (redness): 1 person, 50.00%
- Nausea (feeling of having an urge to vomit): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Sebaceous glands overactivity?
Check whether Sebaceous glands overactivity is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Treatments, associated drugs and conditions:
- Paroxysmal supraventricular tachycardia (15,789 reports)
- Sebaceous glands overactivity (52 reports)
COVID vaccines that are related to Sebaceous glands overactivity:
- Sebaceous glands overactivity in Moderna COVID Vaccine
- Sebaceous glands overactivity in Pfizer BioNTech Covid Vaccine
- Sebaceous glands overactivity in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Sebaceous glands overactivity:
- Sebaceous glands overactivity (60 drugs)
All the conditions that are associated with Sebaceous glands overactivity:
- Sebaceous glands overactivity (54 conditions)
How the study uses the data?
The study is based on Sebaceous glands overactivity and Paroxysmal supraventricular tachycardia, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sumatriptan Succinate and Aortic Arteriosclerosis - 7 seconds ago
- Clexane and C-Reactive Protein Abnormal - 14 seconds ago
- Sodium Alginate and Foetal Exposure During Pregnancy - 14 seconds ago
- Amlodipine Besylate and Drug Level Fluctuating - 14 seconds ago
- Exforge Hct and Effexor Xr drug interaction - 20 seconds ago
- Prevacid and Tongue Neoplasm Malignant Stage Unspecified - 22 seconds ago
- Peg-Intron and Abdominal Wall Abscess - 23 seconds ago
- Clopra and Hepatomegaly - 26 seconds ago
- Pantoprazole and Rhabdomyolysis - 29 seconds ago
- Wixela Inhub and Hypotension - 31 seconds ago